Figure 7
Figure 7. B lymphocytes from Noxa−/−/Bim−/− mice resisted induction of apoptosis by AICAR. (A) B cells from WT, Bim−/−, Noxa−/−, and Puma−/− and (B) B cells from WT, Bim−/−, Bim−/−/Noxa−/−, Bim−/−/Puma−/−, and vav-BCL2 transgenic (BCL-2 tg) mouse spleen were incubated for 12 hours with AICAR in a range of concentrations (0.05, 0.1, 0.25, and 0.5mM). Viability was measured by flow cytometry, and it is expressed as the percentage of the viability of untreated cells. Data are mean ± SEM from 3 to 6 independent experiments for each genotype. ***P < .005, **P < .01, *P < .05, mutant versus WT B lymphocytes. +++P < .005, +P < .05, mutant versus Bim−/− B lymphocytes.

B lymphocytes from Noxa−/−/Bim−/− mice resisted induction of apoptosis by AICAR. (A) B cells from WT, Bim−/−, Noxa−/−, and Puma−/− and (B) B cells from WT, Bim−/−, Bim−/−/Noxa−/−, Bim−/−/Puma−/−, and vav-BCL2 transgenic (BCL-2 tg) mouse spleen were incubated for 12 hours with AICAR in a range of concentrations (0.05, 0.1, 0.25, and 0.5mM). Viability was measured by flow cytometry, and it is expressed as the percentage of the viability of untreated cells. Data are mean ± SEM from 3 to 6 independent experiments for each genotype. ***P < .005, **P < .01, *P < .05, mutant versus WT B lymphocytes. +++P < .005, +P < .05, mutant versus Bim−/− B lymphocytes.

Close Modal

or Create an Account

Close Modal
Close Modal